W. Hearn

发表

Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity.

D. Mash, C. Wetli, A. J. Ruttenber, 1997, Journal of forensic sciences.

Site-dependent postmortem changes in blood cocaine concentrations.

W. Hearn, E. Keran, H. Wei, 1991, Journal of forensic sciences.

Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter

D. Mash, Stefan Rose, C. Wetli, 1991, Journal of neurochemistry.

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin.

D. Mash, J. Staley, R. Rothman, 1995, Life sciences.

Fatality Due to Acute α-Methyltryptamine Intoxication

W. Hearn, G. Hime, D. M. Boland, 2005 .

High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.

D. Mash, J. Staley, C. Wetli, 1994, The Journal of pharmacology and experimental therapeutics.

Tissue distribution of cocaine in a pregnant woman.

W. Hearn, R. Mittleman, J. Cofino, 1989, Journal of forensic sciences.

Cocaethylene is more potent than cocaine in mediating lethality

D. Mash, W. Hearn, A. Ciarleglio, 1991, Pharmacology Biochemistry and Behavior.

A solid phase extraction technique for the isolation and identification of opiates in urine.

W. Hearn, W. Andollo, W. Huang, 1992, Journal of analytical toxicology.

Fatal diphenhydramine intoxication in infants.

Stephen J. Nelson, A. Baker, J. A. Levisky, 2003, Journal of forensic sciences.

Ibogaine in the treatment of heroin withdrawal.

D. Mash, R. Tyndale, F. Ervin, 2001, The Alkaloids. Chemistry and biology.

Chapter 8 Ibogaine in the treatment of heroin withdrawal

D. Mash, R. Tyndale, F. Ervin, 2001 .

Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence a

D. Mash, M. Norenberg, P. Shapshak, 1998, Annals of the New York Academy of Sciences.

Medication development of ibogaine as a pharmacotherapy for drug dependence.

D. Mash, M. Norenberg, P. Shapshak, 1998, Annals of the New York Academy of Sciences.

Common Methods in Postmortem Toxicology

W. Hearn, H. Walls, 2007 .

Metabolism of monofluoro- and monochlorobenzoates by a denitrifying bacterium

B. F. Taylor, S. Pincus, W. Hearn, 1979, Archives of Microbiology.

Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays.

Madeleine J Swortwood, W Lee Hearn, Anthony P DeCaprio, 2014, Drug testing and analysis.

Recommendations for toxicological investigations of drug-facilitated sexual assaults.

R. Baselt, A. Negrusz, B. Finkle, 1999, Journal of forensic sciences.

Evaluating the relationship between postmortem and antemortem morphine and codeine concentrations in whole blood.

K. Furton, W. Hearn, S. Tolliver, 2010, Journal of analytical toxicology.

Fatal cold medication intoxication in an infant.

E. Lew, W. Hearn, D. Boland, 2003, Journal of analytical toxicology.

Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine

D. Mash, J. Staley, K. Rice, 1996, Psychopharmacology.

Stability of ethanol in postmortem blood and vitreous humor in long-term refrigerated storage.

W. Hearn, Therese Olsen, 2003, Journal of Analytical Toxicology.

Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.

J. Callaway, D. Mckenna, G. S. Brito, 1996, Journal of analytical toxicology.

A New Psilocybian Species of Copelandia

R. Singer, W. Hearn, R. A. Weeks, 1979 .

DUES NOTICES HAVE BEEN MAILED DIRECTLY TO MEMBERS ~ A Closer Look at

A. M.P., W. Hearn, V. Spiehler, 2010 .

m-Hydroxybenzoylecgonine: an important contributor to the immunoreactivity in assays for benzoylecgonine in meconium.

E. Bandstra, W. Hearn, B. Steele, 1993, Journal of analytical toxicology.

Strategies for Postmortem Toxicology Investigation

H. Druid, W. Hearn, 2007 .

Brain biomarkers for identifying excited delirium as a cause of sudden death.

D. Mash, H. Druid, Linda Duque, 2009, Forensic science international.

Introduction to Postmortem Toxicology

W. Hearn, H. Walls, 2007 .

Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry.

W. Hearn, G. Hime, J. Cofino, 1991, Journal of analytical toxicology.

Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.

W. Hearn, G. Hime, D. Mash, 1995, Journal of analytical toxicology.

The use of hair analysis to document a cocaine overdose following a sustained survival period before death.

D. Fetterolf, W. Hearn, G. Hime, 1991, Journal of analytical toxicology.

Drug Contamination of U.S. Paper Currency and Forensic Relevance of Canine Alert to Paper Currency: A Critical Review of the Scientific Literature

F. Rossano, W. Hearn, Jay M. Poupko, 2018, Journal of forensic sciences.

Xylazine toxicity--literature review and report of two cases.

W. Hearn, G. Hime, R. Mittleman, 1998, Journal of forensic sciences.

Death from pool chlorine--an unusual case.

W. Hearn, V. J. Rao, 1988, Journal of forensic sciences.

Fatality due to acute alpha-methyltryptamine intoxication.

W. Hearn, G. Hime, W. Andollo, 2005, Journal of Analytical Toxicology.

Cocaethylene inhibits uptake of dopamine and can reach high plasma concentrations following combined cocaine and ethanol use.

R. Roth, P. Jatlow, J. Taylor, 1990, NIDA research monograph.

A positive THC urinalysis from hemp (Cannabis) seed oil.

J. Callaway, W. Hearn, H. Walls, 1997, Journal of analytical toxicology.

Analysis of cocaine and metabolites in brain using solid phase extraction and full-scanning gas chromatography/ion trap mass spectrometry.

W. Hearn, W. Andollo, A. Hernandez, 1994, Forensic science international.